The study drug is a soft capsule taken by mouth, which is expected to be a more convenient alternative to an injection into a vein or under the skin for resolving HAE attacks.
Clinical research studies help scientists and doctors explore whether a study drug is safe and effective in humans. The data gathered from clinical research helps the development of medical therapies, which may improve your health and the way you receive medical care.
There is no guarantee that the study drug will improve your HAE symptoms, but what researchers learn from the RAPIDe-1 clinical study may lead to better medications for patients with HAE in the future.
The rules and ethics that doctors must follow to practice medicine also apply to clinical research studies. Additional standards called Good Clinical Practice also apply.
Patients with HAE are encouraged to contact a local office to see if they may qualify for this clinical research study. Additionally, patients are recommended to consult their treating health care professional (HCP).
Study-related medication and medical care will be provided at no cost to patients who qualify and are enrolled in the study.
Medical care will take place at local hospitals and research centres that specialize in the treatment of HAE, and care will be provided by qualified and licensed physicians.